Genome Engineering and Synthetic Biology (4th edition)


23 September 2021

De Bijloke

Registration Deadline

09 September 2021

Genome Engineering and Synthetic Biology are revolutionizing Life Sciences. Driven by advances in the CRISPR-toolbox for rapid, cheap, multiplex modification of genomes and breakthroughs in DNA synthesis technologies, the pace of progress enabled by these tools in the last years has been breathtaking.

The first three editions (September 2013, January 2016, January 2018) were a roaring success and we are pleased to announce the 4th edition of GESB in beautiful Ghent in September, 2020.

Travel Grants

We offer 5 travel grants to international attendees, which will reimburse travel costs up to 400 Euros. Are you interested in attending GESB20 and want to have a chance on a travel grant? Submit your motivation below by clicking on the 'Apply for a grant' button before 4 June 2020. The organizing committee will notify you of your travel grant acceptance by the end of June. No registration is needed before submitting a travel grant proposal. When you’re awarded with a travel grant you will receive a practical email containing the next steps. Note that being awarded a travel grant does not mean being registered for the conference. Scroll down to apply for your grant.

Poster information:

Format: A0 (841 x 1189 mm / 33.1 x 46.8 in), portrait orientation


• Edward Lemke - Institute of Molecular Biology (IMB), DE, Johannes Gutenberg University (JGU), DE & EMBL, DE

• Sarah Christine Heilshorn - Stanford University, US

• Jane Langdale - University of Oxford, UK

• George Guo-Qiang Chen - Tsinghua University, CN

• Jason Gammack - Inscripta, US

• Janice Chen - Mammoth Biosciences, US

• Dan Voytas - University of Minnesota, US & Co-Founder & CSO, Calyxt, US

• Alexis Komor - University of California, US

• Fred Van Ex - Inari Agriculture, BE

• Ross Sozzani - NC State Univeristy, US

• Bruno Correia - EPFL, CH

• Patrick Yizhi Cai - Manchester Institute of Biotechnology, University of Manchester, UK

• Tilmann Buerckstuemmer - Aelian Biotechnology, AT

• Peter Smibert - New York Genome Center, Techn Innovation lab, US

• Tara Deans - University of Utah, US

• Jonathan Gootenberg - McGovern Institute, MIT, US

• Steve Harvey - CEO Camena Biosciences, UK

• Rob Marchmont - VP Sphere Fluidics, UK

• Charlie Silver - CEO Mission Bio, US

• Bryan Dickinson - The University of Chicago, US

• Holger Puchta - Botanical Institute, Karlsruhe Institute of Technology (KIT), DE

• Ping-Wei Ho - VIB-KU Leuven Center for Microbiology, BE

• And more to come!